JAVIER
ESCANED BARBOSA
Profesor asociado de Ciencias de la Salud
![Foto de JAVIER](/img/uploaded/B1C208A8E1820F13282153D4BA39B96E.jpg)
![Foto de Universidade de São Paulo](/img/noimage_org.png)
Universidade de São Paulo
São Paulo, BrasilPublicaciones en colaboración con investigadores/as de Universidade de São Paulo (11)
2023
-
Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week
Journal of the American College of Cardiology, Vol. 81, Núm. 5, pp. 505-514
2022
-
Sustained Safety and Performance of a Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Long-Term Data of the BIOSOLVE-II First-in-Man Trial at 5 Years
Cardiovascular Revascularization Medicine, Vol. 38, pp. 106-110
-
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e417-e427
2021
-
Impact of Endothelial Shear Stress on Absorption Process of Resorbable Magnesium Scaffold: A BIOSOLVE-II Substudy
Cardiovascular Revascularization Medicine, Vol. 29, pp. 9-15
2019
-
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study
Cardiovascular Revascularization Medicine, Vol. 20, Núm. 5, pp. 392-398
-
Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary artery lesions: An optical coherence tomography analysis
European Heart Journal Cardiovascular Imaging, Vol. 20, Núm. 8, pp. 916-924
-
Serial 3-Dimensional Optical Coherence Tomography Assessment of Jailed Side-Branch by Second-Generation Drug-Eluting Absorbable Metal Scaffold (from the BIOSOLVE-II Trial)
American Journal of Cardiology, Vol. 123, Núm. 7, pp. 1044-1051
2018
-
In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris — DREAMS 2G) in de novo coronary lesions: Insights from the BIOSOLVE-II First-In-Man Trial
International Journal of Cardiology, Vol. 255, pp. 22-28
2016
-
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo threevessel disease
EuroIntervention, Vol. 12, Núm. 2, pp. e224-e234
-
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial
The Lancet, Vol. 387, Núm. 10013, pp. 31-39
-
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
European Heart Journal, Vol. 37, Núm. 35, pp. 2701-2709